Top 10 for 2011: Most-Read Ophthalmology Articles

Lauri R. Graham


December 08, 2011

What did ophthalmologists read on Medscape during 2011? We looked back to find out and compiled a list of the most popular articles for this year.

For ophthalmologists, it seemed to boil down to money, Medicare, malpractice, and medicine, although not necessarily in that order. With the still struggling economy and the continuing threat of declining reimbursements, it is not surprising that articles pertaining to money and Medicare were popular. Also not surprising is that any news surrounding Avastin® (bevacizumab) and Lucentis® (ranibizumab) in the treatment of neovascular ("wet") age-related macular degeneration continue to resonate with readers. The year brought bright spots too, with exciting innovations in technology and ongoing developments in treatment, including the use of the femtosecond laser for cataract surgery, the advance of corneal collagen cross-linking for keratoconus, and the promise of novel drug delivery systems for glaucoma.

The most popular articles, as determined by how many of our members chose to read them, are provided below. If you missed these important articles, please take a minute to review them and see what your colleagues are reading.

10. Precision Laser System Approved for Cataract Surgery

9. Novel Drug Delivery Systems for Glaucoma

8. Quinupristin/Dalfopristin in Staphylococcus aureus Endophthalmitis

7. Causes of Cataract Surgery Malpractice Claims

6. Advances in Keratoconus Treatment

5. Daily Aspirin Tied to Risk of Macular Degeneration

4. Avastin (bevacizumab) and Lucentis (ranibizumab)

3. Medicare and the sustainable growth rate

2. Money and the business of medicine

And the number one most-read article by ophthalmologists on Medscape in 2011 was...


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.